Andrew J. Schwab, 10% Owner: Enliven Therapeutics ELVN Sell · Filed 24/02/16

Trade details

Type: Insider sale
Amount: $10,256,534.2
Shares · price: 688,358 sh · $14.90 a share
Held after: 3,200,634 sh
Stock: Enliven Therapeutics ELVN
Person: Andrew J. Schwab10% Owner
Trade date: 24/02/14
Filed: 24/02/16
Days to filing: 2 days

Sold 17.7% of holdings

Share of holding sold: 17.7%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/15~24/03/15

Andrew J. Schwab's recent trades

Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$184.9K
114,851 sh
$184.9K
Filed 09/24
Traded 09/23
Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$45.6K
27,612 sh
$45.6K
Filed 09/24
Traded 09/22
Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$7,290
4,528 sh
$7,290
Filed 09/24
Traded 09/23
Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$1,795
1,088 sh
$1,795
Filed 09/24
Traded 09/22
Andrew J. Schwab10% Owner
SellEntrada Therapeutics
Sell
Entrada Therapeutics
TRDA
$1.8M
200,000 sh
$1.8M
Filed 25/11/18
Traded 25/11/14

Andrew J. Schwab, 10% Owner — sold $10.3M of Enliven Therapeutics ELVN · 17.7% of holdings | Whalegun